GSK to axe U.S. jobs as part of $1.6 billion cost cuts: sources
LONDON (Reuters) – GlaxoSmithKline will this week inform U.S. staff of hundreds of job cuts in its biggest market as the drugmaker starts implementing a major cost-saving program, sources familiar with the matter said on Sunday.
